CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 397812-397937 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"EGIS-8332 and GYKI 53405 reduced both the core (56%, 50%, respectively) and total brain infarctions (33%, 28%, respectively).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T31060","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T31060","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T92","span":{"begin":0,"end":125},"obj":"Sentence"}],"attributes":[{"subj":"T92","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1335","span":{"begin":82,"end":87},"obj":"Body_part"}],"attributes":[{"id":"A1335","pred":"uberon_id","subj":"T1335","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"subj":"T1335","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2606","span":{"begin":82,"end":99},"obj":"Disease"},{"id":"T20984","span":{"begin":82,"end":99},"obj":"Disease"}],"attributes":[{"id":"A2606","pred":"mondo_id","subj":"T2606","obj":"http://purl.obolibrary.org/obo/MONDO_0005394"},{"id":"A51307","pred":"mondo_id","subj":"T20984","obj":"http://purl.obolibrary.org/obo/MONDO_0005394"},{"subj":"T2606","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T20984","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93cbec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#e5ec93"},{"id":"CORD-19-PD-UBERON","color":"#d893ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecbe"}]}]}}